These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus. Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749 [TBL] [Abstract][Full Text] [Related]
25. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression. Proust A; Rincé P; Creidy R; Lazure T; Joab I; Garçon L; Fabre M; Guettier C; Raphael M Am J Pathol; 2011 Oct; 179(4):1630-7. PubMed ID: 21871426 [TBL] [Abstract][Full Text] [Related]
27. Characteristics of Epstein-Barr virus associated childhood non-Hodgkin's lymphoma in the Republic of Korea. Kim D; Ko Y; Suh Y; Koo H; Huh J; Lee W Virchows Arch; 2005 Sep; 447(3):593-6. PubMed ID: 15991005 [TBL] [Abstract][Full Text] [Related]
28. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders. Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Marques-Piubelli ML; Salas YI; Pachas C; Becker-Hecker R; Vega F; Miranda RN Pathology; 2020 Jan; 52(1):40-52. PubMed ID: 31706670 [TBL] [Abstract][Full Text] [Related]
30. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders. Afify ZAM; Taj MM; Orjuela-Grimm M; Srivatsa K; Miller TP; Edington HJ; Dalal M; Robles J; Ford JB; Ehrhardt MJ; Ureda TJ; Rubinstein JD; McCormack S; Rivers JM; Chisholm KM; Kavanaugh MK; Bukowinski AJ; Friehling ED; Ford MC; Reddy SN; Marks LJ; Smith CM; Mason CC Cancer; 2023 Mar; 129(5):780-789. PubMed ID: 36571557 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly. Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629 [TBL] [Abstract][Full Text] [Related]
32. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472 [TBL] [Abstract][Full Text] [Related]
33. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age? Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931 [TBL] [Abstract][Full Text] [Related]
35. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553 [TBL] [Abstract][Full Text] [Related]
36. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly. Wang E; Papavassiliou P; Sebastian S Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037 [TBL] [Abstract][Full Text] [Related]
37. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases. Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262 [TBL] [Abstract][Full Text] [Related]
38. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival. Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103 [TBL] [Abstract][Full Text] [Related]
39. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases]. Chen DB; Wang Y; Song QJ; Shen DH Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829 [TBL] [Abstract][Full Text] [Related]
40. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease. Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]